iDexis Semaglutide Ban Ordered By High Court
iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.
Lenacapavir HIV Prevention Injection: SA Rollout Faces Heat
The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.
Semaglutide Compounding Dispute: Novo Nordisk Heads To Court
The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections.
Compounded GLP-1 Injections Spark Regulatory Battle
Compounded GLP-1 injections are at the centre of a regulatory dispute. iDexis challenges SAHPRA and SAPC recall orders.
Illicit GLP-1 Manufacturing Halted In Pretoria Raid
Learn how SAHPRA is addressing illicit GLP-1 manufacturing following recent raids on compounding pharmacies in Pretoria.